in vitro antilithiatic activity
TRANSCRIPT
-
8/9/2019 In Vitro AntiLithiatic Activity
1/4
IN VITRO ANTI-UORLITHIATIC ACTIVITY OF SAMPA-SAMPALUKAN (Phyllanthus niruri)
ETHANOLIC LEAF EXTRACT TO CALCUIM OXOLATE CRYSTAL INDUCED MICE
(Mus musculus).
Jerico O. Julaton IV-Phoenix
RESEARCH PROPOSAL
INTRODUCTION
All over the world especially in developing countries, approximately 8! o" population continues to
use traditional medicine in primarymedical pro#lems. In the past decade, there"ore, research has #een"ocused
on scienti"ic evaluation o" traditional drugs o" plant origin. $here is an urgent need to systematically evaluate
the plants used intraditional medicine. %uch research could lead to new drugdiscovery or advance use o"
indigenous her#al medicines "ortreatment. $his revival o" interest in plant derived drugs is mainly due to the
current widespread #elie" that green medicine is sa"e andmore dependa#le than the costly synthetic drugs
many o" which have adverse side e""ects.
&rolithiasis is characteri'ed #y the "ormation o" a stone in the (idneys or urinary tracts. A large
num#er o" people, nearly )*+! o" the human populations are su""ering "rom urinary stone pro#lem all over
the glo#e.$he crystals o" calcium oxalate aOx/ are the primary constituent o" more than 0! o" the
ma1ority o" human (idney stones2 they exist in the "orm o" aOx monohydrate O3/ and aOx dihydrate
O4/ 567. $he pathogenesis o" calcium oxalate stone "ormation is a multi-step process and in essence
includesnucleation, crystal growth, crystal aggregation and crystal retention. $he stone "ormation reuires
supersaturated urine. %upersaturation also depends on urinary p9, ionic strength, solute concentration and
complexations. In spite o" su#stantial progress in the pathophysiology and treatment o" urolithiasis, there is no
satis"actory drug #eing used in clinical therapy. :ndoscopic stone removal and extracorporeal shoc( wave
lithotripsy are prohi#itively costly and recurrence is uite common with these procedures. $hus a drug "or the
prevention o" this disease or its recurrence would #e o" great interest. Phyllanthus niruri ;inn.
-
8/9/2019 In Vitro AntiLithiatic Activity
2/4
traditional systems o" medicine vi'., Ayurveda, &nanai and %idha. =rom the ancient time the tri#al and rural
people o" our country commonly used this her# in treating various disorders. P. niruri has also #een used
traditionally "or treating liver pro#lems li(e hepatitis, elimination o" mucous, (idney stones and diuretic
pro#lems .
>eeping a#ove (nowledge in the mind, current study was done to "ind out the stone "ormation
inhi#itor e""ect and stone dissolving e""ect o" P. niruri extracts.
HYPOTHESIS
$his study aims to "ind out the inhi#itory activity o" :thanolic ;ea" :xtract "rom %ampa-sampalu(an
Phyllanthus-niruri/ against calcium oxalate crystal induced mice. It sought to answer two speci"ic uestions.
a. Is enthanolic lea" extract o" %ampa-sampalu(an P. niruri/ is e""ective as a treatment "or &rinary
stone associated with calcium oxalate crystal induced mice.
#. Is there a signi"icant e""ect on the inhi#iton o" calcium oxalate crystal induced mice #etween the
trestments levels A,
-
8/9/2019 In Vitro AntiLithiatic Activity
3/4
Material a!" Met#$"
%.& Pla!t Material
P .niruri leaves were collected "rom 9imamaylan ?9%. It grows into anher#al garden in ourschool , Voucher specimen was dried in shade and stored in air tight container at @ "or "urther
study.
%.% E'trati$! a!" I$lati$!
$he leaves are pulverised and a#out 0 gms o" powder was extracted with chloro"orm and
aueous in soxhlet, also extracted successively with acetone, #en'ene, petroleum ether, Alcohol. All
extracts were concentrated on a water #ath and residue was dried in a desiccator. All the preparedextracts were su#1ected to ualitative chemical tests to detect the presenceo" di""erent classes o"
phytoconstituents. $; studies were done "or identi"ying the presence o" constituents which are
detected in chemical tests and to (nown how many extracts are present in each extracts . $hisseparated parameter is su#1ected "or physical, chemical and spectral study &V/. And positive results
"or two "ractions were ta(en "or pharmacological evaluation.
%. E*al+ati$! ,$r A!ti-+r$lit#iati Ati*it
Ste-&/ Prearati$! $, e'eri0e!tal 1i"!et$!e (Cali+0 $'alate t$!e) 2 #$0$3e!$+
reiitati$!/
:uimolar solutiono" alcium chloride dihydrate A/ in distilledwater and %odium oxalateA/ in +ml o" @?9@%O) were allowed to react in su""icientuantity o" distilled water in a #ea(er.
$he resulting precipitate was calcium oxalate. :uimolar solution o" alcium chloride dehydrate
A/ in distilled water and 4isodium hydrogenphosphate A/ in +ml o" @? 9@%O)/, wasallowed to react in su""icient uantity o" distilled water in a #ea(er. $he resulting precipitate
wascalcium phosphate.
-
8/9/2019 In Vitro AntiLithiatic Activity
4/4
in the #eginning, to (now how much uantity o" calcium oxalate actually test su#stances/ could
dissolve.
Data A!ali
4ata will #e collected #e"ore and a"ter the application o" extract or the pre-test, posttestexperimental design. $he initial weight must #e measured and a"ter the application. $he initial and
"inal weight a"ter application is compared with each other and the ! o" dissolution with a di""erent
treatment levels.
Statitial T$$l Ue"
One way around the pro#lem is to compare the groups on di""erences #etween post-test and
pretest, sometimes called #a!3e $reor 3ai! $re. 5"igure7 $he test can #e carried out in anum#er o" euivalent waysG
t-test o" the di""erences2
@-group A?OVA o" the di""erences,
repeated measures analysis o" variance.
Re,ere!e
Jain 3,